Clinical Microbiology and Infection,
Journal Year:
2024,
Volume and Issue:
30(10), P. 1312 - 1318
Published: June 25, 2024
ObjectivesAmong
people
receiving
opioid-agonist
treatment
(OAT),
the
risk
of
COVID-19
infection
and
disease
may
be
higher
owing
to
underlying
health
problems
vulnerable
social
circumstances.
We
aimed
determine
whether
recent
OAT,
when
compared
with
past
exposure,
affected
(i)
testing
for
SARS-CoV-2,
(ii)
positive
(iii)
being
hospitalized
or
dying
disease.MethodsWe
included
individuals
prescribed
OAT
in
Scotland
from
2015
2020.
performed
record
linkage
SARS-CoV-2
PCR
testing,
vaccination,
hospitalization,
mortality
data,
followed
up
March
2020
December
2021.
used
proportional
hazards
analysis
multivariate
logistic
regression
estimate
associations
between
prescription
(in
previous
2
months),
exposure
(off
over
a
year),
outcomes.
Models
were
adjusted
confounders.ResultsAmong
36
093
19
071
(52.9%)
tested
SARS-CoV-2;
2896
(8.3%)
positive;
552
(1.5%)
died
COVID-19.
Recent
was
associated
lower
odds
among
those
(aOR,
0.63;
95%
CI,
0.57–0.69).
However,
positive,
two-fold
hospitalization
death
2.04;
1.60–2.59).DiscussionWe
found
that
infection,
but
once
diagnosed.
Clinical
studies
are
needed
unravel
role
these
associations.
An
enhanced
effort
is
warranted
increase
vaccine
coverage
patients
mitigate
severe
consequences
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(2), P. 1526 - 1526
Published: Jan. 14, 2023
(1)
The
harm-reduction
benefits
of
opioid
agonist
treatment
(OAT)
are
well-established;
however,
the
UK
government’s
emphasis
on
“recovery”
may
be
contributing
to
a
high
proportion
people
leaving
and
low
retention
rates.
We
wanted
develop
rich
nuanced
understanding
factors
that
might
influence
journeys
who
use
OAT.
(2)
explored
at
each
level
socioecological
system
considered
ways
these
interact
in
carried
out
semi-structured
interviews
with
OAT
(n
=
12)
service
providers
13)
analysed
data
using
reflexive
thematic
analysis.
(3)
developed
three
themes
representing
participant
perceptions
These
were:
System
is
Broken;
Power
Struggles;
Filling
Void.
(4)
Conclusions:
suggest
prioritisation
important
preserve
Stigma
systemic
issue
which
presents
multiple
barriers
living
fulfilling
lives.
There
an
urgent
need
targeted
interventions
address
stigma
towards
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 10, 2025
Abstract
Background
The
COVID-19
pandemic
significantly
disrupted
substance
use
services,
potentially
exacerbating
existing
inequities
in
access
to
treatment.
This
study
examines
the
perspectives
of
senior
managers
and
decision-makers
Wales
regarding
equity
issues
services
during
pandemic.
Methods
Semi-structured
interviews
were
conducted
with
fifteen
from
various
organisations
field
Wales.
Interviews
autumn
2020.
Data
analysed
using
thematic
analysis
identify
key
themes
related
Results
Key
findings
highlighted
significant
disparities
between
third
sector
statutory
NHS
particularly
PPE,
recognition
as
essential
workers.
rapid
shift
digital
service
provision
exposed
a
divide,
excluding
vulnerable
users.
However,
also
accelerated
innovations
delivery,
such
introduction
long-acting
injectable
buprenorphine
revised
take-home
medication
policies.
Long-term
concerns
included
economic
impact
on
populations,
potential
increases
mental
health
use,
funding
uncertainties
for
services.
Conclusions
exacerbated
while
driving
innovation.
Findings
suggest
need
greater
support
strategies
address
sustained
ensure
equitable
These
insights
can
inform
policy
practice
develop
more
resilient
preparation
any
future
crises.
Harm Reduction Journal,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Feb. 4, 2023
Abstract
Background
The
ongoing
COVID-19
pandemic
has
disproportionately
affected
structurally
vulnerable
populations
including
people
who
use
drugs
(PWUD).
Increased
overdose
risk
behaviors
among
PWUD
during
the
have
been
documented,
with
research
underscoring
role
of
influencing
factors
such
as
isolation
and
job
loss
in
these
behaviors.
Here,
we
qualitative
methods
to
examine
impact
pandemic-related
response
measures
on
drug
a
sample
Rhode
Island.
Using
social-ecological
framework,
highlight
nested,
interactive
levels
pandemic’s
influence
increased
Methods
From
July
October
2021,
semi-structured
interviews
were
conducted
18
self-reported
any
increase
associated
(e.g.,
use,
change
type
and/or
more
solitary
use)
relative
before
pandemic.
Thematic
analysis
was
using
codebook
salient
themes
identified
from
interview
guides
those
that
emerged
through
close
reading
transcribed
interviews.
Guided
by
grouped
into
individual,
network,
institutional,
policy-level
influences
Results
Individual-level
included
anxiety
depression,
loneliness,
boredom.
Network-level
changes
local
supply
social
network
composition
specific
housing.
At
institutional
level,
patterns
influenced
reduced
access
harm
reduction
or
treatment
services.
policy
related
financial
changes,
loss,
business
closures.
All
participants
corresponded
several
nested
levels.
Conclusions
Participants
multi-level
their
behavior
risk.
These
findings
suggest
effective
large-scale
crises,
pandemic,
must
address
concurrently.
Harm Reduction Journal,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: May 8, 2024
Abstract
Background
Substance
use
disorder
treatment
and
recovery
support
services
are
critical
for
achieving
maintaining
recovery.
There
limited
data
on
how
structural
social
changes
due
to
the
COVID-19
pandemic
impacted
individual-level
experiences
with
substance
treatment-related
among
community-based
samples
of
people
who
inject
drugs.
Methods
People
a
recent
history
injection
drug
were
enrolled
in
AIDS
Linked
IntraVenous
Experience
study
Baltimore,
Maryland
participated
one-time,
semi-structured
interview
between
July
2021
February
2022
about
their
living
through
(n
=
28).
An
iterative
inductive
coding
process
was
used
identify
themes
describing
affected
participants’
services.
Results
The
median
age
participants
54
years
(range
24–73);
10
(36%)
female,
16
(57%)
non-Hispanic
Black,
8
(29%)
HIV.
We
identified
several
that
acted
as
barriers
facilitators
engagement
medications
opioid
(MOUD)
(e.g.,
group
meetings).
New
take-home
methadone
flexibility
policies
temporarily
facilitated
MOUD
treatment,
but
other
pre-existing
rigid
practices
zero-tolerance)
counteracting
barriers.
Changes
illicit
market
both
facilitator
barrier
treatment.
Decreased
availability
pandemic-related
adaptations
in-person
While
telehealth
expansion
meetings
some
participants,
faced
digital
technological
These
service
provision
also
led
diminished
perceived
quality
virtual
meetings.
However,
increased
accessibility
individual
providers
counselors
Sponsors).
Conclusions
Structural
across
socioecological
levels
created
new
Multilevel
interventions
needed
improve
access
high-quality
Harm Reduction Journal,
Journal Year:
2022,
Volume and Issue:
19(1)
Published: July 22, 2022
Abstract
Background
The
impact
of
public
health
policies
during
the
COVID-19
pandemic
on
people
who
inject
drugs
(PWID)
has
varied
across
regions.
In
other
countries,
recent
research
shown
that
PWID
access
to
harm
reduction
services,
despite
rapid
adaptations,
been
negatively
impacted.
Our
study
describes
these
impacts
in
a
rural
state.
Methods
We
conducted
semi-structured
interviews
with
PWID,
community
partners,
and
healthcare
providers
state
Maine
(USA).
explored
how
changes
made
impacted
including
basic
services
(i.e.,
shelter),
syringe
service
programs,
safe
drug
supply,
low
barrier
treatment,
peer
support.
Interviews
were
analyzed
using
framework
method
apply
Penchansky’s
model
access,
Saurman’s
modification,
which
includes
six
dimensions
access—accessibility,
availability,
acceptability,
affordability,
accommodation,
awareness.
Results
interviewed
thirty-six
stakeholders
(
N
=
9
providers,
18
PWID).
Policies
such
as
mobile
outreach
expansion,
mail
delivery
equipment,
relaxed
telemedicine
regulations
facilitated
accessibility
programs
buprenorphine
treatment.
Public
policies,
social
distancing
screening
reduced
contact,
subsequently
acceptability
awareness
many
services.
Elimination
one-for-one
needle
exchange
some
areas
increased,
perception
service),
affordability
for
PWID.
However,
actually
began
enforcing
policy,
Conclusions
Changes
resulting
from
have
all
among
While
barriers
unavoidable
pandemic,
we
found
specific
policy
decisions
mitigated
barriers,
while
exacerbated
them.
Relaxing
particularly
helpful
facilitating
by
giving
organizations
flexibility
adapt
evolving
needs
These
results
can
inform
optimally
mitigate
negative
during,
beyond,
pandemic.
Housing Care and Support,
Journal Year:
2024,
Volume and Issue:
27(1), P. 64 - 76
Published: March 23, 2024
Purpose
The
COVID-19
pandemic
has
affected
many
industries,
and
reports
indicate
that
this
includes
the
illicit
drug
market.
Recent
research
suggests
homeless
are
particularly
vulnerable
during
pandemic,
UK
Government
acted
to
house
rough
sleepers.
Research
is
scarce
regarding
people’s
experiences
of
This
study
aims
explore
supply
in
COVID-19.
Design/methodology/approach
Eight
people
who
use
drugs,
residing
hostels
for
Southampton,
participated
semi-structured
one-on-one
telephone-based
interviews.
Findings
A
thematic
analysis
revealed
five
themes:
availability
presence
dealers,
quality
finances
personal
experiences.
Participants
reported
varying
supply,
with
lockdown
measures
expressed
as
main
reason
reduced
supplies,
users
found
it
difficult
find
dealers
generate
income
purchasing
drugs.
limitations/implications
results
may
lack
generalisability
wider
population,
such
sleepers
suggesting
a
need
further
into
on
topic
could
be
more
in-depth
through
methods
convenient
population.
Practical
implications
Services
should
invest
harm
reduction
services
encourage
drugs
engage
substitution
treatment.
Homeless
provide
psychological
support
Social
changes
behaviour
following
have
their
interactions
rest
society
(e.g.
begging
town
centres
reduce).
These
also
change
way
can
best
people.
Originality/value
partially
consistent
other
findings
about
supply;
however,
they
suggest
some
individuals
experienced
minimal
supply.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(5), P. 655 - 655
Published: April 23, 2024
We
investigated
the
impacts
of
COVID-19
pandemic
on
hepatitis
C
(HCV)
treatment
initiation,
including
by
birth
cohort
and
injection
drug
use
status,
in
British
Columbia
(BC),
Canada.
Using
population
data
from
BC
Cohort,
we
conducted
interrupted
time
series
analyses,
estimating
changes
HCV
initiation
following
introduction
pandemic-related
policies
March
2020.
The
study
included
a
pre-policy
period
(April
2018
to
2020)
three
follow-up
periods
December
2020,
January
2021,
2022).
level
decreased
26%
April
2020
(rate
ratio
0.74,
95%
confidence
interval
[CI]
0.60
0.91).
Overall,
no
statistically
significant
difference
occurred
over
2021
post-policy
periods,
an
increase
34.4%
(95%
CI
0.6
75.8)
2022
(equating
321
additional
people
initiating
treatment),
relative
expectation.
Decreases
for
born
between
1965
1974
(25.5%)
who
inject
drugs
(24.5%),
In
summary,
was
associated
with
short-term
disruptions
BC,
which
were
greater
drugs.
International Journal of Drug Policy,
Journal Year:
2023,
Volume and Issue:
117, P. 104048 - 104048
Published: May 8, 2023
As
with
other
areas
of
life,
drug
markets
have
been
impacted
by
the
COVID-19
pandemic
and
related
restrictions.
This
article
examines
how
structurally
vulnerable
people
who
use
drugs
(PWUD)
experienced
adapted
to
changes
in
street
caused
lockdown
measures.The
builds
on
ethnographic
fieldwork
two
Danish
cities
2020,
including
in-depth
interviews
22
PWUD,
20
service
providers,
low-threshold
providers
outreach
workers.The
most
consistently
reported
effect
measures
local
increases
cannabis
prices.
Accounts
availability
varied
greatly,
some
participants
reporting
changing
while
others
described
situation
as
similar
pre-lockdown
conditions.
Rather
than
a
long-term
shortage,
anticipated
disruption
scarcity,
restrictions
access
cash
sellers
seeking
capitalize
crisis.Although
no
scarcity
was
seen,
anticipation
shortage
sufficient
impact
market
dynamics.
Heterogeneity
PWUDs'
experiences
during
can
degree
be
explained
terms
their
embeddedness
social
networks.
While
proved
resilient
measures,
PWUD
less
embedded
networks
were
more
shifts
sellers'
over-pricing
drugs.
International Journal of Drug Policy,
Journal Year:
2023,
Volume and Issue:
118, P. 104075 - 104075
Published: May 22, 2023
In
anticipation
of
COVID-19
related
disruptions
to
opioid
use
disorder
(OUD)
care,
new
provincial
and
federal
guidance
for
the
management
OUD
risk
mitigation
(RMG)
prescription
pharmaceutical
opioids
were
introduced
in
British
Columbia,
Canada,
March
2020.
This
study
evaluated
combined
impacts
pandemic
counteracting
policies
on
enrollment
medications
(MOUD).
Using
data
from
three
cohorts
people
with
presumed
Vancouver,
we
conducted
an
interrupted
time
series
analysis
estimate
effects
impact
prevalence
MOUD
overall,
as
well
individual
MOUDs
(methadone,
buprenorphine/naloxone,
slow-release
oral
morphine)
between
November
2018
2021,
controlling
pre-existing
trends.
sub-analysis
considered
RMG
together
MOUD.
We
included
760
participants
OUD.
post-COVID-19
period,
morphine
rates
showed
estimated
immediate
increase
level
(+7.6%,
95%
CI:
0.6%,
14.6%
1.8%,
0.3%,
3.3%,
respectively),
followed
by
a
decline
monthly
trend
(-0.8%
per
month,
−1.4%,
−0.2%
−0.4,
−0.1,
respectively).
There
no
significant
changes
trends
methadone,
or
when
Despite
improvements
this
beneficial
reversed
over
time.
appeared
have
provided
additional
benefits
sustain
retention
care.